Synonyms: Example 1 [WO2016119505A1] | Keprason®
keverprazan is an approved drug (China (2023))
Compound class:
Synthetic organic
Comment: Keverprazan (hydrochloride) is a potassium ion-competitive acid blocker (P-CAB) [3], that was developed to decrease gastric acid production. P-CABs inhibit the gastric H+,K+-ATPase, and are therapeutic alternatives to long-used proton pump inhibitors [4].
P-CABs are an evolving class of drugs, the first of which to enter clinical use was revaprazan in 2007 (S Korea). |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. China (2023) |
IUPAC Name ![]() |
1-[5-(2-fluorophenyl)-1-[3-(3-methoxypropoxy)phenyl]sulfonylpyrrol-3-yl]-N-methylmethanamine |
Synonyms ![]() |
Example 1 [WO2016119505A1] | Keprason® |
Database Links ![]() |
|
GtoPdb PubChem SID | 483123201 |
PubChem CID | 132164139 |
Search Google for chemical match using the InChIKey | UDHVRDAZIAGHFG-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UDHVRDAZIAGHFG |
UniChem Compound Search for chemical match using the InChIKey | UDHVRDAZIAGHFG-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UDHVRDAZIAGHFG-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
P-CAB agent 2 (links to external site)
Cat. No. HY-153219A |